Celvivo

Odense, Denmark · Founded 2014 · Privately Held (backing)

Developer of a 3D cell culture technology designed to grow cells so that they retain or recover their in vivo physiological attributes. Celvivo is based in Odense, Denmark and was founded in 2014. Its last reported valuation was $25.7 million in May 2025. It has raised $10.9 million.

Last reported valuation
$25.7M
Oct 2026
Priced at
—
Total raised
$10.9M
Last round
—

Who backs Celvivo?

4 investors
InvestorType
Denmark's Export and Investment FundVenture capital
T&W MedicalFamily office
EUREKA Network—
Innovationsfonden—
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Celvivo investors

4 investors are on record for Celvivo, including Denmark's Export and Investment Fund, T&W Medical, EUREKA Network and Innovationsfonden.

Free account
More of Celvivo with a free account
  • ·Watch Celvivo: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 4 firms already write checks for companies like Celvivo. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View